UltraShape Ltd. (Syneron Medical)
- Company typePrivate
- Founded-
- HeadquartersWayland, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What UltraShape Ltd. (Syneron Medical) does
UltraShape Ltd. operates as a non-invasive body-shaping technology provider within the Syneron Medical / Candela Corporation aesthetic device portfolio. UltraShape's original FDA-cleared modality uses focused, pulsed ultrasound energy to selectively destroy fat cells without surgery, targeting the non-invasive fat-reduction segment of medical aesthetics. The technology was originally developed and commercialized as a standalone company before being acquired by Syneron Medical, which later rebranded the combined entity as Candela Corporation; UltraShape now sits alongside Candela's broader laser, IPL, RF microneedling, and hydrodermabrasion product family.
Under the Candela umbrella, the combined business sells capital-equipment aesthetic treatment systems — including Nordlys (IPL/laser), PicoWay (picosecond laser), Vbeam (pulsed-dye laser), Gentle Pro Series (laser hair removal), Matrix (RF microneedling), and Glacē (hydrodermabrasion) — directly to medical providers such as dermatologists, plastic surgeons, general doctors, hospitals, and med spas. Revenue is generated primarily through hardware sales of these systems to practitioner customers, with no publicly disclosed pricing or per-treatment economics.
The go-to-market operates as a B2B-to-B2C model: the company reaches patients indirectly through provider channels rather than delivering treatments directly, and supports this with a patient-facing website (localized into six languages) that hosts treatment education, brand portfolio information, and a "Find a Treatment Provider" tool to funnel consumer demand to installed-base providers. The company is US-based (Wayland, MA), private, and operates with 101-250 employees, serving global markets through direct field sales and international distribution.
UltraShape Ltd. (Syneron Medical) firmographics
Firmographics- Name
- UltraShape Ltd. (Syneron Medical)
- Legal name
- Candela Corporation
- Website
- https://ultrashape.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
UltraShape Ltd. (Syneron Medical) industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Laser & Energy-Based Dermatology (HLAKACAF)
Keywords
Where UltraShape Ltd. (Syneron Medical) is headquartered
LocationHeadquarters
- HQ city
- Wayland
- HQ country
- United States
- HQ region
- North America
Markets served
UltraShape Ltd. (Syneron Medical) business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Medical Aesthetic Device Sales: Sale of laser and light-based aesthetic treatment systems to medical providers including dermatologists, plastic surgeons, hospitals, and med spas. These are capital equipment purchases for medical practices.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
UltraShape Ltd. (Syneron Medical) product offering
Product offeringCore offering
UltraShape is an FDA-cleared, non-invasive body-shaping procedure that uses focused, pulsed ultrasound energy to selectively destroy fat cells. The company manufactures and sells medical aesthetic devices including laser systems (Nordlys IPL, PicoWay picosecond laser, Vbeam pulsed-dye laser, Gentle Pro Series), radiofrequency microneedling (Matrix), and advanced hydrodermabrasion (Glacē) systems to dermatologists, plastic surgeons, hospitals, and med spas.
Product overview
Candela offers a comprehensive portfolio of medical aesthetic devices for non-invasive and minimally invasive treatments. The product line includes laser systems (Nordlys® IPL/laser, PicoWay® picosecond laser, Vbeam® pulsed-dye laser, Gentle Pro™ Series laser), radiofrequency microneedling (Matrix™), and advanced hydrodermabrasion (Glacē™). These systems collectively address treatments for hair removal, hyperpigmentation, skin rejuvenation, skin resurfacing, tattoo removal, vascular lesions, scars, and stretch marks.
Differentiator
Problem solved
Functional benefit
Brands
- Nordlys®: Intense pulsed light (IPL) treatment for acne, vascular conditions, hair removal, and skin texture
- PicoWay®
- Vbeam®
- Gentle Pro™ Series
- Matrix™
- Glacē™
Products and services
- Nordlys®
Companies that use UltraShape Ltd. (Syneron Medical)
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles1 record
UltraShape Ltd. (Syneron Medical) technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
UltraShape Ltd. (Syneron Medical) partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
UltraShape Ltd. (Syneron Medical) competitors and assessment
Company assessmentDirect peers
- BTL Aesthetics: Direct peer in non-invasive body shaping and skin tightening, with energy-based platforms (EMSCULPT, EMFACE, Exilis) that compete in adjacent body-contouring and facial-treatment indications. Same provider channel and B2B sales motion.
- InMode: Direct peer in minimally invasive and energy-based aesthetic devices, particularly strong in RF microneedling (Morpheus8), body contouring, and laser platforms. Aggressive challenger in many of the same provider accounts as Candela.
- Sciton: Direct peer in laser and light-based aesthetic and medical devices, with comparable platforms in skin resurfacing, vascular treatments, and hair removal. Sells into plastic surgery and dermatology practices with a similar premium capital equipment model.
- Cynosure (Hologic): Direct peer in the medical aesthetic laser and energy-based device market, with overlapping product lines in hair removal, skin revitalization, and body contouring. Comparable B2B-to-provider sales motion and similar end customer mix of dermatologists, plastic surgeons, and med spas.
- Venus Concept: Direct peer in energy-based aesthetic devices, offering laser, RF, and PEMF-based platforms. Targets a similar mix of dermatologists, plastic surgeons, and med spas with a subscription-based business model twist on the same provider channel.
- Cutera: Direct peer in aesthetic lasers and energy-based devices for hair removal, skin revitalization, and body sculpting. Sells into the same dermatologist, plastic surgeon, and med-spa channels with comparable capital equipment sales motion.
- Alma Lasers: Direct peer offering a multi-modality portfolio of laser, IPL, RF, and ultrasound-based aesthetic platforms. Targets the same dermatologist, plastic surgeon, and med-spa customer base with a comparable global distribution footprint.
- Solta Medical (Bausch Health): Direct peer with established brands (Thermage, Fraxel, Clear+Brilliant, Liposonix) overlapping Candela's RF microneedling (Matrix) and laser skin rejuvenation lines. Comparable B2B model into the same provider end markets.
- Lumenis (Boston Scientific Aesthetic Business): Direct peer in energy-based aesthetic devices, particularly strong in IPL and CO2 laser systems. Now part of Boston Scientific's aesthetics franchise, competing head-to-head with Candela's Nordlys and Vbeam franchises in dermatology practices.
Broad incumbents
- AbbVie (Allergan Aesthetics): Broad incumbent in the broader medical aesthetics market via injectables (Botox, fillers) and the SkinMedica skincare line. Not a direct device competitor, but operates in the same provider offices and end-patient demand pool, shaping purchase decisions for energy-based device add-ons like Candela's portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
UltraShape Ltd. (Syneron Medical) social profiles
Digital presenceUltraShape Ltd. (Syneron Medical) financial estimates
Financial estimateRevenue estimate
Valuation estimate
UltraShape Ltd. (Syneron Medical) leadership team
Management profileNumber of profiles
UltraShape Ltd. (Syneron Medical) funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UltraShape Ltd. (Syneron Medical) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UltraShape Ltd. (Syneron Medical)
What does UltraShape Ltd. (Syneron Medical) do?
UltraShape is an FDA-cleared, non-invasive body-shaping procedure that uses focused, pulsed ultrasound energy to selectively destroy fat cells. The company manufactures and sells medical aesthetic devices including laser systems (Nordlys IPL, PicoWay picosecond laser, Vbeam pulsed-dye laser, Gentle Pro Series), radiofrequency microneedling (Matrix), and advanced hydrodermabrasion (Glacē) systems to dermatologists, plastic surgeons, hospitals, and med spas.
Is UltraShape Ltd. (Syneron Medical) a public or private company?
UltraShape Ltd. (Syneron Medical) is a private company. It is classified as venture growth investor backed and is currently operating.
When was UltraShape Ltd. (Syneron Medical) founded?
UltraShape Ltd. (Syneron Medical) was founded in -1. It employs 101 to 250 people.
Where is UltraShape Ltd. (Syneron Medical) based?
UltraShape Ltd. (Syneron Medical) is headquartered in Wayland, United States, in the North America region.
How does UltraShape Ltd. (Syneron Medical) make money?
One revenue line is on record: medical Aesthetic Device Sales.
Who are UltraShape Ltd. (Syneron Medical)'s main competitors?
Direct peers on record are BTL Aesthetics, InMode, Sciton, Cynosure (Hologic), Venus Concept, Cutera, Alma Lasers, Solta Medical (Bausch Health) and Lumenis (Boston Scientific Aesthetic Business). AbbVie (Allergan Aesthetics) is listed as a broad incumbent.
Does UltraShape Ltd. (Syneron Medical) have an API?
No public API is recorded for UltraShape Ltd. (Syneron Medical).
What industry is UltraShape Ltd. (Syneron Medical) in?
UltraShape Ltd. (Syneron Medical)'s product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology. Its NAICS code is 334510 and its SIC code is 3841.